Antibody Information
General Information of This Antibody
| Antibody ID | ANI0QYT100 |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | SHR-1920 |
|||||
| Antigen Name | B-cell antigen receptor complex-associated protein beta chain (CD79B) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
SHR-A1912 [Phase 1]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05113069 | Clinical Status | Phase 1 | ||
| Clinical Description |
An open-label, single-arm, multicenter, phase 1 study to estimate the safety, tolerability, pharmacokinetics, and efficacy of SHR-A1912 in patients with b-cell lymphoma.
|
||||
References